<?xml version='1.0' encoding='utf-8'?>
<document id="25552565"><sentence text="Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention."><entity charOffset="0-8" id="DDI-PubMed.25552565.s1.e0" text="Morphine" /></sentence><sentence text="Morphine is recommended in patients with ST-segment-elevation myocardial infarction, including those undergoing primary percutaneous coronary intervention"><entity charOffset="0-8" id="DDI-PubMed.25552565.s2.e0" text="Morphine" /></sentence><sentence text=" Suboptimal antiplatelet effect during and after primary percutaneous coronary intervention is associated with increased thrombotic complications" /><sentence text=" It was hypothesized a potential drug-drug interaction between morphine and antiplatelet agents"><entity charOffset="63-71" id="DDI-PubMed.25552565.s4.e0" text="morphine" /></sentence><sentence text=" We sought to assess platelet inhibition after a loading dose of the currently recommended antiplatelet agents in ST-segment-elevation myocardial infarction patients according to morphine use"><entity charOffset="179-187" id="DDI-PubMed.25552565.s5.e0" text="morphine" /></sentence><sentence text="" /><sentence text="Three hundred patients undergoing primary percutaneous coronary intervention receiving either prasugrel (n = 95) or ticagrelor (n = 205) loading dose had platelet reactivity assessed by VerifyNow 1, 2, and 4 hours after loading dose"><entity charOffset="94-103" id="DDI-PubMed.25552565.s7.e0" text="prasugrel" /><entity charOffset="116-126" id="DDI-PubMed.25552565.s7.e1" text="ticagrelor" /><pair ddi="false" e1="DDI-PubMed.25552565.s7.e0" e2="DDI-PubMed.25552565.s7.e0" /><pair ddi="false" e1="DDI-PubMed.25552565.s7.e0" e2="DDI-PubMed.25552565.s7.e1" /></sentence><sentence text=" Patients treated with morphine (n = 95; 32%) had a higher incidence of vomit (15% versus 2%; P = 0"><entity charOffset="23-31" id="DDI-PubMed.25552565.s8.e0" text="morphine" /></sentence><sentence text="001)" /><sentence text=" P2Y12 reactivity units 2 hours after the loading dose was 187 (153-221) and 133 (102-165) in patient with and without morphine (P &lt; 0"><entity charOffset="119-127" id="DDI-PubMed.25552565.s10.e0" text="morphine" /></sentence><sentence text="001); the difference persisted after excluding patients with vomit (P &lt; 0" /><sentence text="0001)" /><sentence text=" High residual platelet reactivity (P2Y12 reactivity units â‰¥ 208) at 2 hours was found in 53% and 29% patients with and without morphine (P &lt; 0"><entity charOffset="128-136" id="DDI-PubMed.25552565.s13.e0" text="morphine" /></sentence><sentence text="001) and without difference between prasugrel and ticagrelor patients"><entity charOffset="36-45" id="DDI-PubMed.25552565.s14.e0" text="prasugrel" /></sentence><sentence text=" The independent predictors of high residual platelet reactivity at 2 hours were morphine use (odds ratio, 2"><entity charOffset="81-89" id="DDI-PubMed.25552565.s15.e0" text="morphine" /></sentence><sentence text="91 [1" /><sentence text="71-4" /><sentence text="97]; P &lt; 0" /><sentence text="0001) and age (odds ratio, 1" /><sentence text="03 [1" /><sentence text="01-1" /><sentence text="05]; P = 0" /><sentence text="010)" /><sentence text=" Morphine remained associated with high residual platelet reactivity after propensity score adjustment (c-statistic, 0"><entity charOffset="1-9" id="DDI-PubMed.25552565.s24.e0" text="Morphine" /></sentence><sentence text="68; 95% confidence interval, 0" /><sentence text="66-0" /><sentence text="70; P = 0" /><sentence text="879 for Hosmer-Lemeshow test)" /><sentence text="" /><sentence text="In patients with ST-segment-elevation myocardial infarction, morphine use is associated with a delayed onset of action of the oral antiplatelet agents"><entity charOffset="61-69" id="DDI-PubMed.25552565.s30.e0" text="morphine" /></sentence><sentence text=" This association persisted after adjusting for the propensity to receive morphine and after excluding patients with vomit"><entity charOffset="74-82" id="DDI-PubMed.25552565.s31.e0" text="morphine" /></sentence><sentence text="" /></document>